Administration of erythropoietin in patients with myocardial infarction: does it make sense? An updated and comprehensive meta-analysis and systematic review-Reference-Cited by-同舟云学术

Administration of erythropoietin in patients with myocardial infarction: does it make sense? An updated and comprehensive meta-analysis and systematic review

Published:2015-04 Issue:3 Volume:16 Page:179-189
ISSN:1553-8389
Container-title:Cardiovascular Revascularization Medicine
language:en
Short-container-title:Cardiovascular Revascularization Medicine

Author:

Ali-Hassan-Sayegh Sadegh,Mirhosseini Seyed Jalil,Tahernejad Mahbube,Mahdavi Parisa,Haddad Fatemeh,Shahidzadeh Azadeh,Lotfaliani Mohammad Reza,Sedaghat-Hamedani Farbod,Kayvanpour Elham,Weymann Alexander,Sabashnikov Anton,Popov Aron-Frederik

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Reference43 articles.

1. 2014 ESC/EACTS Guidelines on myocardial revascularization

2. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions;Levine;Circulation,2011

3. Future treatment strategies in ST-segment elevation myocardial infarction;Windecker;Lancet,2013

4. Carperitide and adiponectin: how are they connected each other to benefit acute decompensated heart failure?;Asanuma;Circ J,2009

5. Treatment with recombinant placental growth factor (PlGF) enhances both angiogenesis and arteriogenesis and improves survival after myocardial infarction;Takeda;Circ J,2009

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Asialo-rhuEPO as a Potential Neuroprotectant for Ischemic Stroke Treatment;Pharmaceuticals;2023-04-18

2. The role of anemia on admission in acute coronary syndrome - An umbrella review of systematic reviews and meta-analyses;International Journal of Cardiology;2022-11

3. Are There Any Cardioprotective Effects or Safety Concerns of Erythropoietin in Patients With Myocardial Infarction? A Systematic Review;Cureus;2022-06-05

4. Potential Therapeutic Benefits of Sodium-Glucose Cotransporter 2 Inhibitors in the Context of Ischemic Heart Failure: A State-Of-The-Art Review;Cardiovascular & Hematological Agents in Medicinal Chemistry;2021-08-09

5. Erythropoietin in Lupus: Unanticipated Immune Modulating Effects of a Kidney Hormone;Frontiers in Immunology;2021-03-16